Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 8
2006 6
2007 6
2008 8
2009 10
2010 3
2011 8
2012 6
2013 7
2014 7
2015 2
2016 3
2017 2
2018 6
2019 4
2020 1
2021 1
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Valganciclovir for symptomatic congenital cytomegalovirus disease.
Kimberlin DW, Jester PM, Sánchez PJ, Ahmed A, Arav-Boger R, Michaels MG, Ashouri N, Englund JA, Estrada B, Jacobs RF, Romero JR, Sood SK, Whitworth MS, Abzug MJ, Caserta MT, Fowler S, Lujan-Zilbermann J, Storch GA, DeBiasi RL, Han JY, Palmer A, Weiner LB, Bocchini JA, Dennehy PH, Finn A, Griffiths PD, Luck S, Gutierrez K, Halasa N, Homans J, Shane AL, Sharland M, Simonsen K, Vanchiere JA, Woods CR, Sabo DL, Aban I, Kuo H, James SH, Prichard MN, Griffin J, Giles D, Acosta EP, Whitley RJ; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Kimberlin DW, et al. Among authors: prichard mn. N Engl J Med. 2015 Mar 5;372(10):933-43. doi: 10.1056/NEJMoa1404599. N Engl J Med. 2015. PMID: 25738669 Free PMC article. Clinical Trial.
New therapies for human cytomegalovirus infections.
Britt WJ, Prichard MN. Britt WJ, et al. Among authors: prichard mn. Antiviral Res. 2018 Nov;159:153-174. doi: 10.1016/j.antiviral.2018.09.003. Epub 2018 Sep 15. Antiviral Res. 2018. PMID: 30227153 Review.
The development of new therapies for human herpesvirus 6.
Prichard MN, Whitley RJ. Prichard MN, et al. Curr Opin Virol. 2014 Dec;9:148-53. doi: 10.1016/j.coviro.2014.09.019. Epub 2014 Oct 22. Curr Opin Virol. 2014. PMID: 25462447 Free PMC article. Review.
Investigating N-arylpyrimidinamine (NAPA) compounds as early-stage inhibitors against human cytomegalovirus.
Parsons AJ, Ophir SI, Gardner TJ, Paredes JC, Stein KR, Kwasny SM, Cardinale SC, Torhan M, Prichard MN, James SH, Atanasoff KE, G-Dayanandan N, Bowlin TL, Opperman TJ, Tortorella D. Parsons AJ, et al. Among authors: prichard mn. Antiviral Res. 2023 Jan;209:105474. doi: 10.1016/j.antiviral.2022.105474. Epub 2022 Nov 26. Antiviral Res. 2023. PMID: 36511318 Free PMC article.
New approaches to antiviral drug discovery (genomics/proteomics).
Prichard MN. Prichard MN. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007. Chapter 67. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007. Chapter 67. PMID: 21348063 Free Books & Documents. Review.
82 results